science
Innovative, long-acting treatments
Improving treatment outcomes
Camurus uses the company’s strong R&D expertise and proprietary FluidCrystal® technology in an effort to develop innovative, long-acting treatments with the goal of significantly improving the lives of people with severe and chronic diseases.
Products
Addressing important unmet medical needs
Camurus’ products are based on the company’s proprietary FluidCrystal technology and are designed to address important unmet medical needs.
R&D Pipeline
Diversified pipeline
Camurus’ clinical pipeline represents a robust mix of in-house and partnered programs from early to late-stage development
Technology
Long-acting drug release
Camurus’ FluidCrystal® technology is designed to provide treatment efficacy over extended periods – from days to months – with a single injection.
Scientific congresses
Camurus US is participating at a range of international and regional conferences in the United States to network, discuss and take part in knowledge sharing of latest scientific research and experiences from clinical practice with the common aim of improving care for people with severe and chronic diseases.
Investigator sponsored studies (ISS) and grants
Camurus is committed to advancing medical and scientific knowledge about Camurus’ products and associated therapeutic areas and diseases through research collaborations. See ISS and Grants below for more information: